Management of chronic hepatitis in drug addicts: A systematic review

Adriano M. Pellicelli, G. Barbaro, G. Barbarini, F. Soccorsi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Injection drug users constitute the largest group of person at high risk for acquiring chronic hepatitis C, B and Delta. In particular viral, host and environmental factors all seem to favour rapid spread of these infections among drugs addicts. Host factors include behaviours that expose individuals to hepatitis virus such as the shared use of drug preparation, injection equipment and not protected sexual relationship with other drugs users. While in some clinical studies adherence to treatment regimens was often poor and to treat chronic hepatitis in injection drug users was stated as futile, in other controlled clinical studies adherence and sustained biological response to antiviral treatment was slightly lower or similar to that reported in other groups of patients. In this review we describe the epidemiology, diagnosis and treatment of chronic hepatitis C, B and Delta in intravenous drug users.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalClinica Terapeutica
Volume159
Issue number1
Publication statusPublished - Jan 2008

Fingerprint

Chronic Hepatitis
Drug Users
Chronic Hepatitis B
Chronic Hepatitis C
Injections
Hepatitis Viruses
Drug Compounding
Antiviral Agents
Epidemiology
Therapeutics
Equipment and Supplies
Infection
Clinical Studies

Keywords

  • Chronic viral hepatitis
  • Drugs addiction
  • Interferon alpha

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pellicelli, A. M., Barbaro, G., Barbarini, G., & Soccorsi, F. (2008). Management of chronic hepatitis in drug addicts: A systematic review. Clinica Terapeutica, 159(1), 41-49.

Management of chronic hepatitis in drug addicts : A systematic review. / Pellicelli, Adriano M.; Barbaro, G.; Barbarini, G.; Soccorsi, F.

In: Clinica Terapeutica, Vol. 159, No. 1, 01.2008, p. 41-49.

Research output: Contribution to journalArticle

Pellicelli, AM, Barbaro, G, Barbarini, G & Soccorsi, F 2008, 'Management of chronic hepatitis in drug addicts: A systematic review', Clinica Terapeutica, vol. 159, no. 1, pp. 41-49.
Pellicelli, Adriano M. ; Barbaro, G. ; Barbarini, G. ; Soccorsi, F. / Management of chronic hepatitis in drug addicts : A systematic review. In: Clinica Terapeutica. 2008 ; Vol. 159, No. 1. pp. 41-49.
@article{75c62e22a3a84d5387e4f4676e27c462,
title = "Management of chronic hepatitis in drug addicts: A systematic review",
abstract = "Injection drug users constitute the largest group of person at high risk for acquiring chronic hepatitis C, B and Delta. In particular viral, host and environmental factors all seem to favour rapid spread of these infections among drugs addicts. Host factors include behaviours that expose individuals to hepatitis virus such as the shared use of drug preparation, injection equipment and not protected sexual relationship with other drugs users. While in some clinical studies adherence to treatment regimens was often poor and to treat chronic hepatitis in injection drug users was stated as futile, in other controlled clinical studies adherence and sustained biological response to antiviral treatment was slightly lower or similar to that reported in other groups of patients. In this review we describe the epidemiology, diagnosis and treatment of chronic hepatitis C, B and Delta in intravenous drug users.",
keywords = "Chronic viral hepatitis, Drugs addiction, Interferon alpha",
author = "Pellicelli, {Adriano M.} and G. Barbaro and G. Barbarini and F. Soccorsi",
year = "2008",
month = "1",
language = "English",
volume = "159",
pages = "41--49",
journal = "Clinica Terapeutica",
issn = "0009-9074",
publisher = "Societa Editrice Universo",
number = "1",

}

TY - JOUR

T1 - Management of chronic hepatitis in drug addicts

T2 - A systematic review

AU - Pellicelli, Adriano M.

AU - Barbaro, G.

AU - Barbarini, G.

AU - Soccorsi, F.

PY - 2008/1

Y1 - 2008/1

N2 - Injection drug users constitute the largest group of person at high risk for acquiring chronic hepatitis C, B and Delta. In particular viral, host and environmental factors all seem to favour rapid spread of these infections among drugs addicts. Host factors include behaviours that expose individuals to hepatitis virus such as the shared use of drug preparation, injection equipment and not protected sexual relationship with other drugs users. While in some clinical studies adherence to treatment regimens was often poor and to treat chronic hepatitis in injection drug users was stated as futile, in other controlled clinical studies adherence and sustained biological response to antiviral treatment was slightly lower or similar to that reported in other groups of patients. In this review we describe the epidemiology, diagnosis and treatment of chronic hepatitis C, B and Delta in intravenous drug users.

AB - Injection drug users constitute the largest group of person at high risk for acquiring chronic hepatitis C, B and Delta. In particular viral, host and environmental factors all seem to favour rapid spread of these infections among drugs addicts. Host factors include behaviours that expose individuals to hepatitis virus such as the shared use of drug preparation, injection equipment and not protected sexual relationship with other drugs users. While in some clinical studies adherence to treatment regimens was often poor and to treat chronic hepatitis in injection drug users was stated as futile, in other controlled clinical studies adherence and sustained biological response to antiviral treatment was slightly lower or similar to that reported in other groups of patients. In this review we describe the epidemiology, diagnosis and treatment of chronic hepatitis C, B and Delta in intravenous drug users.

KW - Chronic viral hepatitis

KW - Drugs addiction

KW - Interferon alpha

UR - http://www.scopus.com/inward/record.url?scp=40549129365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549129365&partnerID=8YFLogxK

M3 - Article

C2 - 18399262

AN - SCOPUS:40549129365

VL - 159

SP - 41

EP - 49

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 1

ER -